Back to Search
ANNE PARADA PHARMD
PHARMD
Pharmacist
NPI: 1003529108Individual
Specialties, Licenses & Credentials
Ambulatory Care Pharmacist
Pharmacist — Ambulatory Care
Code: 1835P2201X
26024595A(IN)
PharmacistPrimary
Pharmacist
Code: 183500000X
26024595A(IN)
Research & Publications (20)
Testing the equivalence of different ovine PrP genotypes for estimated breeding values.
PMID 17651323·J Anim Breed Genet·2007
7-preclinical
Effect of different wood pretreatments on the sorption-desorption of linuron and metalaxyl by woods.
PMID 18642844·J Agric Food Chem·2008
8-other
The impact of measuring patient-reported outcomes in clinical practice: a systematic review of the literature.
PMID 18175207·Qual Life Res·2008
1-meta
Microbiological characteristics of "androlla", a Spanish traditional pork sausage.
PMID 16943094·Food Microbiol·2007
7-preclinical
Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney. An infrequent finding.
PMID 17601313·Arch Esp Urol·2007
5-case
[Development of a geographic filter for PubMed to identify studies performed in Spain].
PMID 17194419·Rev Esp Cardiol·2006
8-other
Renal artery duplex ultrasonography as a screening and surveillance tool to detect renal artery stenosis: a comparison with current reference standard imaging.
PMID 16495488·J Ultrasound Med·2006
4-observational
Local and systemic toxicity of h-R3, an anti-epidermal growth factor receptor monoclonal antibody, labeled with 188osmiun after the intracerebral administration in rats.
PMID 15816360·Exp Toxicol Pathol·2005
7-preclinical
Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats.
PMID 12925008·Eur J Neurosci·2003
4-observational
BIA 3-202, a novel catechol-O-methyltransferase inhibitor, reduces the peripheral O-methylation of L-DOPA and enhances its availability to the brain.
PMID 12660477·Pharmacology·2003
4-observational
Catechol-O-methyltransferase inhibition in erythrocytes and liver by BIA 3-202 (1-[3,4-dibydroxy-5-nitrophenyl]-2-phenyl-ethanone).
PMID 12787259·Pharmacol Toxicol·2003
7-preclinical
Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz/b, f/azepine-5-carboxamide, a potent anti-epileptic drug.
PMID 11868969·Xenobiotica·2002
4-observational
Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease.
PMID 12648310·Infect Dis Obstet Gynecol·2002
8-other
The novel anticonvulsant BIA 2-093 inhibits transmitter release during opening of voltage-gated sodium channels: a comparison with carbamazepine and oxcarbazepine.
PMID 11821151·Neurochem Int·2002
4-observational
Effects of carbamazepine and novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives on synaptic transmission in rat hippocampal slices.
PMID 12076316·Pharmacol Toxicol·2002
7-preclinical
Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine.
PMID 11325575·Epilepsy Res·2001
7-preclinical
Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: comparison with carbamazepine.
PMID 11380566·Epilepsia·2001
4-observational
BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
PMID 11412836·Eur J Pharmacol·2001
7-preclinical
Synthesis, anticonvulsant properties and pharmacokinetic profile of novel 10,11-dihydro-10-oxo-5H-dibenz/b,f/azepine-5-carboxamide derivatives.
PMID 11337101·Eur J Med Chem·2001
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8820 S MERIDIAN ST STE 120
INDIANAPOLIS, IN 46217 - Phone
- (317) 865-6700
Quick Facts
- NPI
- 1003529108
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile